A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis
Study title | A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis |
Disease or condition | Eosinophilic esophagitis |
Study type | Interventional (clinical trial) |
Intervention/treatment | Etrasimod (tablet) |
Phase | 2 |
Study site | Duke University |
Study location | Durham, NC |
Principal investigator | David Leiman, MD |
Study coordinator name and email | Chris Efird chris.efird@duke.edu |
Phone Contact | 919-668-5364 |
Clinicaltrials.gov link | https://clinicaltrials.gov/ct2/show/NCT04682639 |